ArticleCureus2025
Wilson Disease Masquerading as Nephrotic Syndrome: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Efficacy of zinc monotherapy in a Wilson's disease adolescent with unusual renal onset: a case report and review of literature.BMC nephrology · 2026Review
- The gut-liver-kidney-brain axis in Wilson disease: copper speciation-flux and barrier-mediated organ crosstalk.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Wilson disease (WD) is a rare, autosomal recessive disorder characterized by defective copper metabolism. Renal manifestations in WD are uncommon, and nephrotic syndrome as an initial presentation is rare. An eight-year-old boy presented with progressive abdominal distension and decreased urine output. Examination revealed pedal edema, ascites, and icterus. Investigations showed nephrotic range proteinuria, elevated liver enzymes, low serum ceruloplasmin, and Kayser-Fleischer rings, confirming a diagnosis of WD with associated nephrotic syndrome. WD presented with nephrotic syndrome and was confirmed by clinical findings, biochemical tests, and slit-lamp examination. The patient was started on oral penicillamine, zinc supplementation, hepatic support, and a copper-restricted diet. Subsequent follow-up showed symptomatic and biochemical improvement. Resolution of ascites and proteinuria was achieved, with stabilization of liver function. The patient was later managed for portal hypertension with spironolactone and propranolol. Hence, nephrotic syndrome can be a rare presenting feature of WD. Early recognition and multidisciplinary management are essential for favorable outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.